Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04659837 · ClinicalTrials.gov registry record · NA

Training Response Inhibition to Obesogenic Foods

A NA study, sponsored by Drexel University.

Completed
Registry status
NA
Development phase
125
Enrollment target

NCT04659837: Completed NA study, sponsored by Drexel University.

NCT04659837 is a NA study that has completed, run by Drexel University. The registered enrollment target is 125 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04659837, a NA study, has completed, sponsored by Drexel University.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target

Study Summary

Dietary choices, and in particular, excess calorie intake leading to obesity, are strong, but reversible risk factors for cancer. For example, foods high in added sugars are low-nutrient, high calorie foods that increase the risk of cancer by promoting weight gain. As such, the reduction of sweets is consistent with American Institute for Cancer Research and the American Cancer Society dietary recommendations. Behavioral interventions to alter diet have limited long-term efficacy, most likely because eating decisions are governed by automatic neurocognitive processes that are not addressed in conventional interventions. In particular, the ability to refrain from consuming unhealthy, but widely available, palatable foods, is increasingly understood to depend on inhibitory control, i.e., the ability to cut off action tendencies that are put in motion by innate drives towards rewarding behaviors. Recent work by our team and others have demonstrated that computer-based inhibitory control trainings result in short-term, specific changes in behavior, such as reducing intake of salty snack food, chocolate, and alcoholic beverages. An automatized, home computer-based inhibitory control training offers the potential of an inexpensive and highly disseminable method of lowering cancer risk across wide swaths of the population. As such, we aim to evaluate the feasibility, acceptability, mechanism of action, effectiveness and persistence of a home computer-based inhibitory control training. In particular, we hypothesize that a high-repetition training in inhibitory control will result in increased adherence to a low-sugar diet, and that effects will be mediated through improved inhibitory control. We further hypothesize that gamefying the training will improve efficacy because it will boost compliance with the daily trainings. We also hypothesize that the training will be most effective for those starting of with impaired inhibitory control, as well as those with strongest desir

Interventions

  • BEHAVIORAL No-Added-Sugar Diet

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2016-06-01
Est. Completion 2019-12-01
Phase NA
Drexel University

92 total trials

What the finished NCT04659837 record still lists

NCT04659837 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which No-Added-Sugar Diet is the first listed.

NCT04659837 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04659837 about?

NCT04659837 is a clinical study titled "Training Response Inhibition to Obesogenic Foods". Dietary choices, and in particular, excess calorie intake leading to obesity, are strong, but reversible risk factors for cancer. For example, foods high in added sugars are low-nutrient, high calorie foods that increase the risk of cancer by promoting weight gain. As such, the reduction of sweets i...

What is the current status of trial NCT04659837?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2016-06-01. Estimated completion is 2019-12-01.

What interventions are being tested in trial NCT04659837?

The interventions under investigation include: No-Added-Sugar Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT04659837?

This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04659837's enrollment target sits among peer trials

125 753rd of 2000 higher than 1,243 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04659837, the US trial registry maintained by the National Library of Medicine. NCT04659837 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.